147 related articles for article (PubMed ID: 22748657)
1. Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies.
Yang J; Nagasawa DT; Spasic M; Amolis M; Choy W; Garcia HM; Prins RM; Liau LM; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):451-8. PubMed ID: 22748657
[TBL] [Abstract][Full Text] [Related]
2. vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins.
Wojtowicz K; Januchowski R; Nowicki M; Zabel M
Anticancer Res; 2017 Jun; 37(6):3015-3023. PubMed ID: 28551640
[TBL] [Abstract][Full Text] [Related]
3. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
[TBL] [Abstract][Full Text] [Related]
4. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
van Zon A; Mossink MH; Schoester M; Houtsmuller AB; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
J Cell Sci; 2003 Nov; 116(Pt 21):4391-400. PubMed ID: 13130096
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.
Szaflarski W; Sujka-Kordowska P; Pula B; Jaszczyńska-Nowinka K; Andrzejewska M; Zawierucha P; Dziegiel P; Nowicki M; Ivanov P; Zabel M
Int J Oncol; 2013 Aug; 43(2):513-20. PubMed ID: 23739867
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a two-repeat fragment of major vault protein.
Kozlov G; Vavelyuk O; Minailiuc O; Banville D; Gehring K; Ekiel I
J Mol Biol; 2006 Feb; 356(2):444-52. PubMed ID: 16373071
[TBL] [Abstract][Full Text] [Related]
7. Structural domains of vault proteins: a role for the coiled coil domain in vault assembly.
van Zon A; Mossink MH; Schoester M; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Biochem Biophys Res Commun; 2002 Mar; 291(3):535-41. PubMed ID: 11855821
[TBL] [Abstract][Full Text] [Related]
8. Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP.
Emre N; Raval-Fernandes S; Kickhoefer VA; Rome LH
Biochim Biophys Acta; 2004 Apr; 1678(1):33-46. PubMed ID: 15093136
[TBL] [Abstract][Full Text] [Related]
9. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
[TBL] [Abstract][Full Text] [Related]
10. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.
Raval-Fernandes S; Kickhoefer VA; Kitchen C; Rome LH
Cancer Res; 2005 Oct; 65(19):8846-52. PubMed ID: 16204055
[TBL] [Abstract][Full Text] [Related]
12. Cellular functions of vaults and their involvement in multidrug resistance.
Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
[TBL] [Abstract][Full Text] [Related]
13. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
Huffman KE; Corey DR
Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
[TBL] [Abstract][Full Text] [Related]
14. The vault complex.
van Zon A; Mossink MH; Scheper RJ; Sonneveld P; Wiemer EA
Cell Mol Life Sci; 2003 Sep; 60(9):1828-37. PubMed ID: 14523546
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Mossink MH; van Zon A; Fränzel-Luiten E; Schoester M; Kickhoefer VA; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2002 Dec; 62(24):7298-304. PubMed ID: 12499273
[TBL] [Abstract][Full Text] [Related]
16. The major vault protein is related to the toxic anion resistance protein (TelA) family.
Suprenant KA; Bloom N; Fang J; Lushington G
J Exp Biol; 2007 Mar; 210(Pt 6):946-55. PubMed ID: 17337707
[TBL] [Abstract][Full Text] [Related]
17. Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
[TBL] [Abstract][Full Text] [Related]
18. Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo.
Liu Y; Snow BE; Kickhoefer VA; Erdmann N; Zhou W; Wakeham A; Gomez M; Rome LH; Harrington L
Mol Cell Biol; 2004 Jun; 24(12):5314-23. PubMed ID: 15169895
[TBL] [Abstract][Full Text] [Related]
19. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Stein U; Bergmann S; Scheffer GL; Scheper RJ; Royer HD; Schlag PM; Walther W
Oncogene; 2005 May; 24(22):3606-18. PubMed ID: 15750632
[TBL] [Abstract][Full Text] [Related]
20. [The structure of cellular vaults, their role in the normal cell and in the multidrug resistance of cancer].
Szaflarski W; Nowicki M; Zabel M
Postepy Biochem; 2011; 57(3):266-73. PubMed ID: 22235652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
